{"disease":{"id":"acute-hyperammonemia-and-associated-encephalopathy","name":"acute hyperammonemia and associated encephalopathy"},"drugs":{"marketed":[{"drug_id":"sodium-phenylacetate","indication_name":"Acute hyperammonemia and associated encephalopathy","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"SODIUM PHENYLACETATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":45,"revenue":null,"mechanism":"Sodium phenylacetate and sodium benzoate provide alternative pathways for nitrogen disposal in patients with urea cycle disorders."}],"pipeline":[],"offLabel":[],"totalMarketed":1,"totalPipeline":0},"trials":{"data":[],"total":0},"guidelines":[],"source":"Drug Landscape verified database"}